Table 2.
Multivariable logistic regression analyses for predicting glycoprotein IIb/IIIa inhibitors administration
| OR | 95% CI | P value | |
|---|---|---|---|
| Age (per 1 year) | 0.98 | 0.98–0.98 | < 0.001 |
| Sex (male) | 1.12 | 1.09–1.16 | < 0.001 |
| Previous stroke | 0.71 | 0.65–0.77 | < 0.001 |
| Previous PCI | 1.12 | 1.08–1.17 | < 0.001 |
| Smoking | 1.07 | 1.04–1.1 | < 0.001 |
| Chronic kidney disease | 0.78 | 0.72–0.85 | < 0.001 |
| Killip class IV on admission | 1.58 | 1.47–1.7 | < 0.001 |
| Ticagrelor or prasugrel | 1.08 | 1.05–1.11 | < 0.001 |
| Cardiac arrest before admission | 0.89 | 0.84–0.95 | < 0.001 |
| Aspiration thrombectomy during PCI | 2.58 | 2.49–2.68 | < 0.001 |
| TIMI 0 or 1 in baseline angiography | 2.3 | 2.22–2.38 | < 0.001 |
| IRA in LMCA and/or LAD | 1.2 | 1.17–1.23 | < 0.001 |
| PCI of bifurcation | 1.24 | 1.18–1.3 | < 0.001 |
| No-reflow during PCI | 3.47 | 3.13–3.84 | < 0.001 |
PCI percutaneous coronary intervention, IRA infarct-related artery, LMCA left main coronary artery, LAD left anterior descending artery, TIMI thrombolysis in myocardial infarction;